shRNA:Article Title: The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells.
Article Snippet: .. [63] The following antibodies were used: ACTIN (Sigma–Aldrich, A5441), FLAG (Sigma–Aldrich, F1804), FLAG (Sigma–Aldrich, F7425), GFP (Santa Cruz, sc-9996), MYC (Santa Cruz, sc-789), APC2 (Cell Signaling Technology, 12301), APC8 (Cell Signaling Technology, 15100), APC10 (Cell Signaling Technology, 14807), APC11 (Cell Signaling Technology, 14090), APC11 (Santa Cruz, sc-517142), SAG (Proteintech, 11905-1-AP), RBX1 (Proteintech, 14895-1-AP), CUL1 (Santa Cruz, sc-11384), CUL5 (Abcam, ab184177), CUL5 (Santa Cruz, sc-373822), CAND1 (Abcam, ab183748), integrin β1 (Cell Signaling Technology, 34 971), p-SRC (Y416) (Cell Signaling Technology, 6943), ATM (Cell Signaling Technology, 2873), Cyclin B1 (Cell Signaling Technology, 4138), RPB1 (Cell Signaling Technology, 14958), EGFR (Cell Signaling Technology, 4267), DEPTOR (Cell Signaling Technology, 11 816), NOXA (Millipore, OP180), UBE2F (Proteintech, 17056-1-AP), COPS5 (Cell Signaling Technology, 6895), SOCS3 (Proteintech, 14025-1-AP), LC3 (Cell Signaling Technology, 2775), securin (Cell Signaling Technology, 13445), ITCH (Proteintech, 20920-1-AP), Cyclin E1 (Cell Signaling Technology, 20808), p-H3 (Cell Signaling Technology, 3377), and p-Aurora A/B/C (Cell Signaling Technology, 2914), Aurora A (Cell Signaling Technology, 14 475), Aurora B (Abcam, ab2254), and NEDD8 (Abcam, ab81264). siRNA and Lentiviral shRNA Silencing: Cells were transfected with the following siRNA oligos by Lipofectamine 2000 (Invitrogen, 11668019) to achieve transient knockdown of endogenous genes. siCtrl: 5′-ATT GTA TGC GAT CGC AGA C-3′; siCUL5: 5′-GCT AGA ATG TTT CAG GAC ATA-3′; siCUL5-2: 5′-GTC TCA CTT CCT ACT GAA CTG-3′; siAPC11: 5′-TCT GCA GGA TGG CAT TTA A-3′; siAPC11-2: 5′-CCA CAT GCA TTG CAT CCT CAA3′; siAPC11-3: 5′-ACT CAT TAA ACT ACT CAA ATC-3′; siAPC2: 5′-TGC GCG GAGTCT TGT TCT TTA-3′; siAPC2-2: 5′-GCAGAT TAA AGCAAG TCAGAT3′; siSAG: 5′-CCT GTG GGT GAA ACA GAA CAA-3′; siSAG-2: 5′-CGA CAA GAT GTT CTC CCT CAA-3′; siUBE2F: 5′-CAA AGT GAA ATG CCT GAC CAA-3′; siUBE2F-2: 5′-CAT CAA ACG TTA TGC CAG AT-3′; siintegrin β1: 5′-GCC CTC CAG ATG ACA TAG AAA-3′; siintegrin β1-2: 5′-GCC TTG CAT TAC TGC TGA TAT-3′; siITCH: 5′-GCC TAT GTT CGG GAC TTC AAA-3′; siITCH-2: 5′-GGT GAC AAA GAG CCA ACA GAG-3′; siWSB1: 5′-AGT TTC TCT CGT ATC GTA TTT-3′; siAREL1: 5′-CCG GGA ATG GTT TGA GCT AAT3′; siTRIP12: 5′-TCG CAA AGG TTA AGA TGA A-3′; siTRAF4: 5′-CCA GGA CAT TCG AAA GCG AAA-3′; siCOPS5: 5′-GCT CAG AGT ATC GAT GAA A-3′; and siCOPS5-2: 5′-CAG TCT CTG AGA AGT ACT TTA-3′. ..
Transfection:Article Title: The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells.
Article Snippet: .. [63] The following antibodies were used: ACTIN (Sigma–Aldrich, A5441), FLAG (Sigma–Aldrich, F1804), FLAG (Sigma–Aldrich, F7425), GFP (Santa Cruz, sc-9996), MYC (Santa Cruz, sc-789), APC2 (Cell Signaling Technology, 12301), APC8 (Cell Signaling Technology, 15100), APC10 (Cell Signaling Technology, 14807), APC11 (Cell Signaling Technology, 14090), APC11 (Santa Cruz, sc-517142), SAG (Proteintech, 11905-1-AP), RBX1 (Proteintech, 14895-1-AP), CUL1 (Santa Cruz, sc-11384), CUL5 (Abcam, ab184177), CUL5 (Santa Cruz, sc-373822), CAND1 (Abcam, ab183748), integrin β1 (Cell Signaling Technology, 34 971), p-SRC (Y416) (Cell Signaling Technology, 6943), ATM (Cell Signaling Technology, 2873), Cyclin B1 (Cell Signaling Technology, 4138), RPB1 (Cell Signaling Technology, 14958), EGFR (Cell Signaling Technology, 4267), DEPTOR (Cell Signaling Technology, 11 816), NOXA (Millipore, OP180), UBE2F (Proteintech, 17056-1-AP), COPS5 (Cell Signaling Technology, 6895), SOCS3 (Proteintech, 14025-1-AP), LC3 (Cell Signaling Technology, 2775), securin (Cell Signaling Technology, 13445), ITCH (Proteintech, 20920-1-AP), Cyclin E1 (Cell Signaling Technology, 20808), p-H3 (Cell Signaling Technology, 3377), and p-Aurora A/B/C (Cell Signaling Technology, 2914), Aurora A (Cell Signaling Technology, 14 475), Aurora B (Abcam, ab2254), and NEDD8 (Abcam, ab81264). siRNA and Lentiviral shRNA Silencing: Cells were transfected with the following siRNA oligos by Lipofectamine 2000 (Invitrogen, 11668019) to achieve transient knockdown of endogenous genes. siCtrl: 5′-ATT GTA TGC GAT CGC AGA C-3′; siCUL5: 5′-GCT AGA ATG TTT CAG GAC ATA-3′; siCUL5-2: 5′-GTC TCA CTT CCT ACT GAA CTG-3′; siAPC11: 5′-TCT GCA GGA TGG CAT TTA A-3′; siAPC11-2: 5′-CCA CAT GCA TTG CAT CCT CAA3′; siAPC11-3: 5′-ACT CAT TAA ACT ACT CAA ATC-3′; siAPC2: 5′-TGC GCG GAGTCT TGT TCT TTA-3′; siAPC2-2: 5′-GCAGAT TAA AGCAAG TCAGAT3′; siSAG: 5′-CCT GTG GGT GAA ACA GAA CAA-3′; siSAG-2: 5′-CGA CAA GAT GTT CTC CCT CAA-3′; siUBE2F: 5′-CAA AGT GAA ATG CCT GAC CAA-3′; siUBE2F-2: 5′-CAT CAA ACG TTA TGC CAG AT-3′; siintegrin β1: 5′-GCC CTC CAG ATG ACA TAG AAA-3′; siintegrin β1-2: 5′-GCC TTG CAT TAC TGC TGA TAT-3′; siITCH: 5′-GCC TAT GTT CGG GAC TTC AAA-3′; siITCH-2: 5′-GGT GAC AAA GAG CCA ACA GAG-3′; siWSB1: 5′-AGT TTC TCT CGT ATC GTA TTT-3′; siAREL1: 5′-CCG GGA ATG GTT TGA GCT AAT3′; siTRIP12: 5′-TCG CAA AGG TTA AGA TGA A-3′; siTRAF4: 5′-CCA GGA CAT TCG AAA GCG AAA-3′; siCOPS5: 5′-GCT CAG AGT ATC GAT GAA A-3′; and siCOPS5-2: 5′-CAG TCT CTG AGA AGT ACT TTA-3′. ..
Knockdown:Article Title: The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells.
Article Snippet: .. [63] The following antibodies were used: ACTIN (Sigma–Aldrich, A5441), FLAG (Sigma–Aldrich, F1804), FLAG (Sigma–Aldrich, F7425), GFP (Santa Cruz, sc-9996), MYC (Santa Cruz, sc-789), APC2 (Cell Signaling Technology, 12301), APC8 (Cell Signaling Technology, 15100), APC10 (Cell Signaling Technology, 14807), APC11 (Cell Signaling Technology, 14090), APC11 (Santa Cruz, sc-517142), SAG (Proteintech, 11905-1-AP), RBX1 (Proteintech, 14895-1-AP), CUL1 (Santa Cruz, sc-11384), CUL5 (Abcam, ab184177), CUL5 (Santa Cruz, sc-373822), CAND1 (Abcam, ab183748), integrin β1 (Cell Signaling Technology, 34 971), p-SRC (Y416) (Cell Signaling Technology, 6943), ATM (Cell Signaling Technology, 2873), Cyclin B1 (Cell Signaling Technology, 4138), RPB1 (Cell Signaling Technology, 14958), EGFR (Cell Signaling Technology, 4267), DEPTOR (Cell Signaling Technology, 11 816), NOXA (Millipore, OP180), UBE2F (Proteintech, 17056-1-AP), COPS5 (Cell Signaling Technology, 6895), SOCS3 (Proteintech, 14025-1-AP), LC3 (Cell Signaling Technology, 2775), securin (Cell Signaling Technology, 13445), ITCH (Proteintech, 20920-1-AP), Cyclin E1 (Cell Signaling Technology, 20808), p-H3 (Cell Signaling Technology, 3377), and p-Aurora A/B/C (Cell Signaling Technology, 2914), Aurora A (Cell Signaling Technology, 14 475), Aurora B (Abcam, ab2254), and NEDD8 (Abcam, ab81264). siRNA and Lentiviral shRNA Silencing: Cells were transfected with the following siRNA oligos by Lipofectamine 2000 (Invitrogen, 11668019) to achieve transient knockdown of endogenous genes. siCtrl: 5′-ATT GTA TGC GAT CGC AGA C-3′; siCUL5: 5′-GCT AGA ATG TTT CAG GAC ATA-3′; siCUL5-2: 5′-GTC TCA CTT CCT ACT GAA CTG-3′; siAPC11: 5′-TCT GCA GGA TGG CAT TTA A-3′; siAPC11-2: 5′-CCA CAT GCA TTG CAT CCT CAA3′; siAPC11-3: 5′-ACT CAT TAA ACT ACT CAA ATC-3′; siAPC2: 5′-TGC GCG GAGTCT TGT TCT TTA-3′; siAPC2-2: 5′-GCAGAT TAA AGCAAG TCAGAT3′; siSAG: 5′-CCT GTG GGT GAA ACA GAA CAA-3′; siSAG-2: 5′-CGA CAA GAT GTT CTC CCT CAA-3′; siUBE2F: 5′-CAA AGT GAA ATG CCT GAC CAA-3′; siUBE2F-2: 5′-CAT CAA ACG TTA TGC CAG AT-3′; siintegrin β1: 5′-GCC CTC CAG ATG ACA TAG AAA-3′; siintegrin β1-2: 5′-GCC TTG CAT TAC TGC TGA TAT-3′; siITCH: 5′-GCC TAT GTT CGG GAC TTC AAA-3′; siITCH-2: 5′-GGT GAC AAA GAG CCA ACA GAG-3′; siWSB1: 5′-AGT TTC TCT CGT ATC GTA TTT-3′; siAREL1: 5′-CCG GGA ATG GTT TGA GCT AAT3′; siTRIP12: 5′-TCG CAA AGG TTA AGA TGA A-3′; siTRAF4: 5′-CCA GGA CAT TCG AAA GCG AAA-3′; siCOPS5: 5′-GCT CAG AGT ATC GAT GAA A-3′; and siCOPS5-2: 5′-CAG TCT CTG AGA AGT ACT TTA-3′. ..
Incubation:Article Title: Exploring the multi-repair effects of advanced biomimetic rapamycin nanoparticles on cerebral ischemia-reperfusion injury
Article Snippet: .. The membranes were subsequently incubated overnight at 4 °C with the following primary antibodies: integrin α4 (1:1,000, CST), integrin β1 (1:1,000, CST), rabbit anti-CD47 (1:500, Bioss), and rabbit anti-β-actin (1:5,000, Bioss). .. After three washes with TBST, the membranes were further incubated for 1 h at room temperature with horseradish peroxidase-conjugated horse goat anti-rabbit secondary antibody (1:2,000, CST).
other:Article Title: Inhibitory effects of β-galactoside α2,6-sialyltransferase 1 on the Hippo pathway in breast cancer cells
Article Snippet: The experiments were performed using the following antibodies: Rabbit antibodies against p-YAP(S127) (#13008S), p-LATS1(T1079) (#8654S), LATS1 (#3477S), p-Src(Y416) (#2101S), p-FAK(Y397) (#8556S), FAK (#3285S), EGFR (#4267S), p-EGFR(Y1068) (#3777S), and integrin β1 (#9699S) were from Cell Signaling Technology; mouse mAb against GAPDH (#sc-365062), and β-actin (#sc-47778) were from Santa Cruz Biotechnology; mouse mAb against integrin α5 (610633) was from BD Biosciences; rabbit pAbs against LPAR4 (22165-1-AP) and mouse mAb against YAP (66900-1-Ig) were obtained from Proteintech; rabbit pAb against ST3GAL4 (NBP1-69565) was obtained from Novus Biologicals; mouse mAbs against FLAG (clone M2, #F3165) and Src (clone GD11, #05-184) were from Sigma; goat pAb against ST6GAL1 (AF5924) was from R&D Systems; mouse mAb against integrin β1 (P5D2) was from Developmental Studies Hybridoma Bank.
|